Anti-Programmed Death Receptor 1 Signalling Immunotherapy as a Part of Curative Intent Strategies for Stages I-III Non-Small Cell Lung Cancer
Surgery provides the best chance of a cure for patients with early stage non-small cell lung cancer (NSCLC) and plays an important role in the multimodal treatment for locally advanced disease. However, many patients still relapse despite intended curative surgery, and no major advances in systemic...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
European Medical Journal
2018-11-01
|
| Rangatū: | European Medical Journal Respiratory |
| Ngā marau: | |
| Urunga tuihono: | https://www.emjreviews.com/respiratory/article/anti-programmed-death-receptor-1-signalling-immunotherapy-as-a-part-of-curative-intent-strategies-for-stages-i-iii-non-small-cell-lung-cancer/ |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|